PUMAS

WIPO WIPO 2022

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark PUMAS was filed as Word mark on 11/17/2022 at the World Intellectual Property Organization.

Trademark Details Last update: August 9, 2023

Trademark form Word mark
File reference 1717663
Register number 6490579
Countries Austria Australia Switzerland China Germany Denmark European Community Spain Finland France United Kingdom Israel India Japan South Korea Sweden Singapore
Base trademark US No. 6490579, September 21, 2021
Application date November 17, 2022
Expiration date November 17, 2032

Trademark owner

14711 Kamputa Dr
Centreville VA 20120
US

Trademark representatives

4101 Lake Boone Trail, Suite 300 Raleigh NC 27607 US

goods and services

09 Downloadable computer software that uses artificial intelligence for managing, accessing and sharing information and data in the fields of performance metrics, data visualizations, and predictive analytics in the healthcare and life sciences industries; downloadable computer software that uses artificial intelligence for conducting mathematical and statistical modeling and simulation of drug effects for third party pharmaceuticals, diagnostic, and health care products; software featuring machine learning and artificial intelligence for data analysis in the fields of data processing, analytics, information processing, data analysis, artificial intelligence, machine learning, deep learning, compound property prediction, compound structure prediction and data visualization in the fields of chemistry, pharmaceutical and agrochemical research and development; downloadable computer software for use in the pharmaceutical industry for drug discovery and design, clinical trial design, and data analysis for guiding experiment and study related decisions, namely, dose selection, patient selection, risk factor identification, endpoint selection, and for identifying genomic markers for efficacy and safety in support of regulatory submission to support product registration; downloadable computer artificial intelligence software for use in the pharmaceutical industry for drug discovery and design, clinical trial design, and data analysis; downloadable computer software for use in biological and chemical research, development, validation and testing in the life sciences field, including primarily the fields of biology, genomics, proteomics and pharmaceuticals for characterizing mechanism of action, understanding systems level biology and pharmacology, guide dose selection, and identify predictors for efficacy and safety; downloadable software platform using machine learning and artificial intelligence for training deep learning models on medical data and for use in medical predictions for use by healthcare organizations, life science and pharmaceutical companies to enhance precision in care quality, improve patient experience and advance new drugs and treatment methods, namely, building translational models, identifying patterns unknown to biology, augmenting systems biology models, enabling quality-by-design for pharmaceutical manufacturing, guiding treatment trajectory, precision dosing, individualized therapy, and extraction of signal from imaging data; downloadable bioinformatics software for use in healthcare information management and analysis, namely, for capturing, storing, aggregating, viewing, and analyzing medical data, medical test results, diagnostic data, slides and specimens, in the fields of healthcare, medical research and clinical research; downloadable software for use in healthcare information management and analysis, namely, for capturing, storing, aggregating, viewing, and analyzing medical data, medical test results, diagnostic data, slides and specimens, in the fields of healthcare, medical research and clinical research; downloadable medical data monitoring software and applications that record, monitor, and analyze medical data, patient data, and provide patient diagnosis risk assessment for identifying trends related to patient treatment
35 Providing business intelligence services in the fields of medical devices, pharmaceuticals and the life sciences
42 Research and development in the field of artificial intelligence software for managing, accessing and sharing information and data in the fields of performance metrics, data visualizations, and predictive analytics in the healthcare and life sciences industries; scientific advisory services in the nature of computer modeling services, namely, computer simulation from computer programs for conducting mathematical and statistical modeling and simulation of drug effects for third party pharmaceuticals, diagnostic, and health care products; design and development of computer software for use in pharmaceutical research and development; scientific research, namely, research and analysis services in the scientific fields of artificial intelligence and machine learning analytics; research and analysis services in the fields of biology, biotechnology, bioinformatics and in the pharmaceutical field; scientific research, namely, providing data analytics and data modelling to others in the fields of medical and pharmaceutical research and development; providing temporary use of web-based software featuring predictive analytics in the healthcare and life sciences industries; providing temporary use of web-based software for managing, accessing, analyzing, and sharing information and data in the healthcare and life sciences industries, namely, information and data in the fields of real world evidence

Trademark history

Date Document number Area Entry
August 4, 2023 2023/32 Gaz DE Rejection
July 31, 2023 2023/31 Gaz CN Rejection
July 28, 2023 2023/31 Gaz FR Rejection
July 26, 2023 2023/30 Gaz EM Rejection
May 18, 2023 2023/21 Gaz AU Rejection
April 26, 2023 2023/18 Gaz FI Rejection
March 27, 2023 2023/14 Gaz IN Rejection
November 17, 2022 2023/8 Gaz US Registration

ID: 141717663